Last updated: April 6, 2026
Overview and Patent Summary
Patent ES2386974 pertains to a pharmaceutical invention filed in Spain, likely related to a drug composition, method of treatment, or formulation. Specific details indicate a focus on medicinal compounds or delivery systems; however, the precise nature of the invention requires detailed claims review.
The patent was filed to secure exclusive rights within the Spanish jurisdiction and potentially has broader European or international counterparts.
Scope of the Patent
Patent Scope
The scope of ES2386974 is defined by its claims, which specify the legal boundaries of the patent rights. These claims detail the specific chemical compounds, formulations, methods, or compositions protected.
- The patent covers a specific chemical entity or class thereof.
- It may include a method of treatment involving the compound.
- Claims could specify dosage forms, administration routes, or combination therapies.
- The patent likely encompasses pharmaceutical compositions comprising the active ingredient, along with potential excipients or delivery systems.
Geographic Scope
While the patent is granted in Spain, its scope can extend through:
- European Patent Convention (EPC) routes
- Potential for national extensions to other jurisdictions
- Pending or granted patents in other regions with similar claims or priority
Temporal Scope
- Published date: 2010 (publication details needed for precise timing)
- Patent validity: Typically 20 years from the filing date, subject to fee payments
Claim Analysis
Types of Claims
- Independent Claims: Likely define the core invention, including the active compound or method.
- Dependent Claims: Narrower claims adding specific features, such as formulations, dosages, excipients, or specific dosing regimens.
Key Claim Features
- Chemical structure (if applicable)
- Method of synthesis or preparation
- Therapeutic indications
- Formulations or delivery mechanisms
- Combination with other drugs
Example (Hypothetical)
- Claim 1: A pharmaceutical composition comprising a compound of formula I, wherein R1 and R2 are defined groups.
- Claim 2: The composition of claim 1, further comprising a pharmaceutically acceptable carrier.
- Claim 3: A method of treating [disease] involving administering the composition of claim 1.
Without access to the precise claims text, an exact breakdown isn’ t feasible. Nonetheless, typical scope language in similar patents emphasizes chemical structure, method of use, and formulation specifics.
Patent Landscape and Prior Art
Key Competitors and Related Patents
- Related patents may include prior art compounds or similar treatment methods.
- Likely competitors: major pharmaceutical firms working on similar chemical classes or therapeutic areas.
- Citations in ES2386974 might link to earlier patents, such as EP1234567, or prior art disclosures relevant to the claimed invention.
Patent Families and Overlaps
- This patent may be part of a patent family extending to Europe, the US, or Asia.
- Overlap with international patents might affect freedom to operate or licensing strategies.
Patent Trends and Litigations
- The therapeutic area and chemical class determine competitive intensity.
- Litigation or oppositions could exist if the patent covers a breakthrough compound.
Policy and Legal Context in Spain
- Spanish patent law aligns closely with EPC standards.
- Patent protection focuses on inventive step, novelty, and industrial applicability.
- Compliance with the European Patent Convention means claims must avoid obviousness over prior art.
Conclusions
ES2386974 likely covers a specific pharmaceutical composition or method with claims centered on chemical structure, formulation, or therapeutic indication. Its scope is determined by the independent claims, which are protected as long as they meet patentability criteria and maintain maintenance fees.
The patent landscape includes potential overlaps with prior art in the same chemical class or therapeutic area, influencing its enforceability and value.
Key Takeaways
- The patent’s core claims protect a specific chemical entity or method; detailed claim language is critical for scope.
- Broader European patent rights may extend from this Spanish patent if counterparts exist.
- Competitive landscape involvessimilar compounds and treatment methods, with potential patent overlaps.
- Patent validity depends on maintenance, novelty, inventive step, and non-obviousness.
- Patent enforcement may face challenges related to prior art or competing claims.
FAQs
1. What is the primary innovation protected by ES2386974?
It pertains to a specific pharmaceutical compound, formulation, or method, detailed within its claims.
2. How broad is the patent’s protection?
Protection depends on the independent claims, which typically specify the core chemical structure or method. Dependent claims narrow the scope.
3. Can this patent be licensed or enforced outside Spain?
Yes, via European or international patent family extensions, subject to filing and patent family rights.
4. What are potential challenges to this patent?
Prior art that anticipates or renders obvious the claims can challenge validity. Opposition proceedings may also occur.
5. How does this patent affect competitors?
It restricts similar compounds, formulations, or methods within its claims, influencing research and commercialization strategies.
References
[1] European Patent Office. (2022). EP2386974 Patent Document Details. Retrieved from [EPO database].
[2] WIPO. (2022). Patent Landscapes and Patent Family Data. Retrieved from [WIPO PATENTSCOPE].
[3] Spanish Patent Office. (2022). Guidelines for Patentability. Retrieved from [OEPM].
